FR2368955A2 - Derives de la tetrahydro-1,2,3,3a indolo (3,2,1-de) (1,5) naphtyridine - Google Patents

Derives de la tetrahydro-1,2,3,3a indolo (3,2,1-de) (1,5) naphtyridine

Info

Publication number
FR2368955A2
FR2368955A2 FR7632319A FR7632319A FR2368955A2 FR 2368955 A2 FR2368955 A2 FR 2368955A2 FR 7632319 A FR7632319 A FR 7632319A FR 7632319 A FR7632319 A FR 7632319A FR 2368955 A2 FR2368955 A2 FR 2368955A2
Authority
FR
France
Prior art keywords
naphthyridine
oxo
indolo
methyl
antianoxia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7632319A
Other languages
English (en)
Other versions
FR2368955B2 (fr
Inventor
Gabor Istvan Koletar
Henry Najer
P Jean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR7632319A priority Critical patent/FR2368955A2/fr
Priority to DD7700198314A priority patent/DD129791A5/xx
Priority to US05/786,557 priority patent/US4190657A/en
Priority to IL51853A priority patent/IL51853A/xx
Priority to MT811A priority patent/MTP811B/xx
Priority to JP52041904A priority patent/JPS5823877B2/ja
Priority to ES457692A priority patent/ES457692A1/es
Priority to YU00948/77A priority patent/YU94877A/xx
Priority to MX775626U priority patent/MX5340E/es
Priority to LU77100A priority patent/LU77100A1/xx
Priority to AT254277A priority patent/AT352741B/de
Priority to DE19772716190 priority patent/DE2716190A1/de
Priority to HUSI001569 priority patent/HU181958B/hu
Priority to DK161377A priority patent/DK143703C/da
Priority to AU24189/77A priority patent/AU506031B2/en
Priority to GB15165/77A priority patent/GB1543283A/en
Priority to NO77771263A priority patent/NO146777C/no
Priority to CA275,948A priority patent/CA1072960A/fr
Priority to SE7704172A priority patent/SE432932B/xx
Priority to AR267179A priority patent/AR214519A1/es
Priority to CS578381A priority patent/CS220344B2/cs
Priority to PT66428A priority patent/PT66428B/fr
Priority to CH450777A priority patent/CH622795A5/fr
Priority to PL19737377A priority patent/PL197373A1/xx
Priority to NL7704004A priority patent/NL7704004A/xx
Priority to NZ183846A priority patent/NZ183846A/xx
Priority to FI771159A priority patent/FI63404C/fi
Priority to IE758/77A priority patent/IE44989B1/en
Priority to SU772470258A priority patent/SU655314A3/ru
Priority to GR53198A priority patent/GR63658B/el
Publication of FR2368955A2 publication Critical patent/FR2368955A2/fr
Priority to AT656178A priority patent/AT355583B/de
Application granted granted Critical
Publication of FR2368955B2 publication Critical patent/FR2368955B2/fr
Priority to FI803790A priority patent/FI803790L/fi
Priority to SE8201181A priority patent/SE8201181L/sv
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Dérivés de la tétrahydro- l,2,3,3a indolo Ø3,2,1-deõ Ø1,5õ naphtyridine répondant la formule générale (Ib), à l'exception de ceux déjà décrits ou exclus dans le brevet principal, considérés sous leurs diverses formes stéréoisomères possibles.
FR7632319A 1976-03-11 1976-10-27 Derives de la tetrahydro-1,2,3,3a indolo (3,2,1-de) (1,5) naphtyridine Granted FR2368955A2 (fr)

Priority Applications (33)

Application Number Priority Date Filing Date Title
FR7632319A FR2368955A2 (fr) 1976-10-27 1976-10-27 Derives de la tetrahydro-1,2,3,3a indolo (3,2,1-de) (1,5) naphtyridine
DD7700198314A DD129791A5 (de) 1976-04-13 1977-04-07 Verfahren zur herstellung von naphtyridinderivaten
IL51853A IL51853A (en) 1976-04-13 1977-04-11 1,2,3,3a-tetrahydro(or 1,2,3,3a,4,5-hexahydro)indolo(3,2,1-de)naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
MT811A MTP811B (en) 1976-04-13 1977-04-11 Indolo (3,2,1-de)(1.5) naphthyzidine derivatives
JP52041904A JPS5823877B2 (ja) 1976-04-13 1977-04-11 ナフチリジン誘導体およびその製造方法
ES457692A ES457692A1 (es) 1976-04-13 1977-04-11 Procedimiento para preparar derivados de naftiridina.
YU00948/77A YU94877A (en) 1976-04-13 1977-04-11 Process for obtaining naphthiridine derivatives
US05/786,557 US4190657A (en) 1976-03-11 1977-04-11 Naphthyridine derivatives
CA275,948A CA1072960A (fr) 1976-04-13 1977-04-12 Derives de l'indolo (3,2,1-de) (1,5) naphthyridine
AT254277A AT352741B (de) 1976-04-13 1977-04-12 Verfahren zur herstellung von neuen naphtyridinderivaten, deren salzen und optischen isomeren
DE19772716190 DE2716190A1 (de) 1976-04-13 1977-04-12 Naphtyridinderivate, ein verfahren zu ihrer herstellung und diese verbindungen als wirkstoffe enthaltende arzneimittel
HUSI001569 HU181958B (hu) 1976-04-13 1977-04-12 Eljárás új l,2,3?3a-tetrahidro-indolo [3,2,1-de] [l,5]naftridin-származékok előállítására
DK161377A DK143703C (da) 1976-04-13 1977-04-12 Analogifremgangsmaade til fremstilling af 1,2,3,3a,4,5-hexahydro-6-oxo-6h-indolo(3,2,1-de)=(1,5)naphthyridin-derivater eller syreadditionssalte deraf
AU24189/77A AU506031B2 (en) 1976-04-13 1977-04-12 Indolo(3, 2, 1-de) (1, 5) naphthyrudune derivatives
GB15165/77A GB1543283A (en) 1976-04-13 1977-04-12 Indolo-(3,2,1-de)(1,5)naphthyridine derivatives
NO77771263A NO146777C (no) 1976-04-13 1977-04-12 Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater
MX775626U MX5340E (es) 1976-04-13 1977-04-12 Procedimiento para preparar derivados de hexahidro 1,2,3,3a.4,5-oxo-6-6h-indolo(3,2,1-de)naftiridina
SE7704172A SE432932B (sv) 1976-04-13 1977-04-12 Analogiforfarande for framstellning av derivat av 1,2,3,3a-tetrahydro-indolo/3,2,1-de/ /1,5/ naftyridin
AR267179A AR214519A1 (es) 1976-04-13 1977-04-12 Procedimiento para obtener tetrahidro-1,2,3,3a-indol-(3,2,1-de)naftiridina
CS578381A CS220344B2 (cs) 1976-04-13 1977-04-12 Způsob výroby nových derivátů naftyridinu
PT66428A PT66428B (fr) 1976-04-13 1977-04-12 Procede de preparation de nouveaux derives de naphtyridine
CH450777A CH622795A5 (fr) 1976-04-13 1977-04-12
LU77100A LU77100A1 (fr) 1976-04-13 1977-04-12
GR53198A GR63658B (en) 1976-04-13 1977-04-13 Process for derivatives preparation of naphyridine
NZ183846A NZ183846A (en) 1976-04-13 1977-04-13 1,2,3,3a,4,5-hexahydro-6h-indolo(3,2,1-de) (1,5)-naphthyridines
FI771159A FI63404C (fi) 1976-04-13 1977-04-13 Foerfarande foer framstaellning av antianoxiska 1,2,3,3a,4,5-hexahydro-6-oxo-6h-indolo(3,2,1-de) (1,5)naftyridiner
IE758/77A IE44989B1 (en) 1976-04-13 1977-04-13 Indolo(3,2,1-d,e)(1,5)naphthyridine derivatives
SU772470258A SU655314A3 (ru) 1976-04-13 1977-04-13 Способ получени производных нафтиридина или их стереоизомеров или их солей
PL19737377A PL197373A1 (pl) 1976-04-13 1977-04-13 Sposob wytwarzania nowych pochodnych 1,2,3,3a-czterowodoroindolo/3,2,1//1,5/naftyrydyny
NL7704004A NL7704004A (en) 1976-04-13 1977-04-13 Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
AT656178A AT355583B (de) 1976-04-13 1978-09-11 Verfahren zur herstellung von neuen naphtyridinderivaten in form ihrer racemate oder ihrer optischen isomere und deren salzen
FI803790A FI803790L (fi) 1976-04-13 1980-12-05 Foerfarande foer framstaellning av antianoxiska 1,2,3,3a,4,5-hexahydro-6-oxo-6h-indolo/3,2,1-de/ /1,5/ naftyridiner
SE8201181A SE8201181L (sv) 1976-04-13 1982-02-25 Forfarande for framstellning av nya derivat av 1,2,3,3a-tetra-hydro-indolo-(3,2,1-de) (1,5)naftyridin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7632319A FR2368955A2 (fr) 1976-10-27 1976-10-27 Derives de la tetrahydro-1,2,3,3a indolo (3,2,1-de) (1,5) naphtyridine

Publications (2)

Publication Number Publication Date
FR2368955A2 true FR2368955A2 (fr) 1978-05-26
FR2368955B2 FR2368955B2 (fr) 1979-02-23

Family

ID=9179251

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7632319A Granted FR2368955A2 (fr) 1976-03-11 1976-10-27 Derives de la tetrahydro-1,2,3,3a indolo (3,2,1-de) (1,5) naphtyridine

Country Status (1)

Country Link
FR (1) FR2368955A2 (fr)

Also Published As

Publication number Publication date
FR2368955B2 (fr) 1979-02-23

Similar Documents

Publication Publication Date Title
IL114690A (en) Antimigraine oxazolidinone substituted indole derivatives
ES356976A1 (es) Un procedimiento para la preparacion de 1h-imidazo-(4, 5-b) pirazin-2-onas sustituidas.
FR2358146A1 (fr) Derives de la tetrahydro-1,2,3,3a indolo(3,2,1-de) (1,5)naphtyridine
FR2374905A2 (fr) Derives de naphtyridine
FR2383182A2 (fr) Nouveaux derives de naphtyridine
FR2383181A2 (fr) Derives de naphtyridine
NL7704004A (en) Indolo-(1,5)-naphthyridine derivs. - having antianoxia and psychotropic activities
FR2368955A2 (fr) Derives de la tetrahydro-1,2,3,3a indolo (3,2,1-de) (1,5) naphtyridine
FR2353550A2 (fr) Procede de preparation de derives de naphtyridine
IT1096815B (it) Derivati della naftiridina
ES396451A1 (es) Procedimiento para la preparacion de derivados de azepina.
ES2100397T3 (es) Espiro(5.5)undecanos 3,9-disubstituidos activos sobre el sistema cardiovascular, proceso para su preparacion y composicion farmaceutica que contiene los mismos.
GB1098835A (en) Spiro-oxazolidinones, spiro-oxazines, their process of preparation and therapeutic compositions containing said derivatives
NZ224956A (en) Benzo-thieno-thiazine derivatives, pharmaceuticals and intermediates
FR2068402A1 (en) Medicaments contg 2-phenyl-benzimidazoles
FR2161051A2 (en) Tricyclic dihydroquinazolinone derivs - with bronchodilating or hypotensive activity
NL7811882A (en) 2-(ortho-aminophenethyl) piperidines - as antiarrhythmic, antiserotonin agents
FR2166101A1 (en) 1,4-di (morpholino,piperidino or pyrrolidino)-7-substd - -pyrido (3,4-d)-pyridazines - as diuretics
FR2254549A1 (en) 3-(Substd. phenyl)-2-chloropropionic acid derivs - hypolipidaemics and hypoglycaemics
GB982252A (en) New cephalosporin compounds and method for preparing same
ES394969A1 (es) Un procedimiento para la preparacion de nuevos 3-alcohil-5-ariloximetilisoxazoles.
FR2042309A1 (en) New heterocyclic antiphlogistic compounds
GB1218590A (en) N-substituted piperidine spiro compounds
FR2378004A2 (fr) Derives de l'argininamide, leur preparation et leurs utilisations therapeutiques
ES394968A1 (es) Un procedimiento para la preparacion de nuevos 3-alcohil-5-ariloximetilisoxazoles.